CMR–derived extracellular volume fraction as a marker for myocardial fibrosis: the importance of coexisting myocardial inflammation

JA Lurz, C Luecke, D Lang, C Besler… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The aim of the present study was to evaluate whether extracellular volume
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …

[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience

P Kellman, JR Wilson, H Xue, WP Bandettini… - Journal of …, 2012 - Elsevier
Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …

CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF

MYM Su, LY Lin, YHE Tseng, CC Chang, CK Wu… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR

G Moravsky, E Ofek, H Rakowski, J Butany… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: In this study we sought to explore the relationship between cardiac magnetic
resonance (CMR) with late gadolinium enhancement (LGE) and histopathological …

Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease

T Podlesnikar, V Delgado, JJ Bax - The international journal of …, 2018 - Springer
The left ventricular (LV) remodeling process associated with significant valvular heart
disease (VHD) is characterized by an increase of myocardial interstitial space with …

[HTML][HTML] Extracellular volume quantification in isolated hypertension-changes at the detectable limits?

TA Treibel, F Zemrak, DM Sado, SM Banypersad… - Journal of …, 2015 - Elsevier
Background Diffuse myocardial fibrosis (DMF) is important in cardiovascular disease,
however until recently could only be assessed by invasive biopsy. We hypothesised that …

Myocardial fibrosis: why image, how to image and clinical implications

R Bing, MR Dweck - Heart, 2019 - heart.bmj.com
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …

Novel imaging techniques for diffuse myocardial fibrosis

DM Sado, AS Flett, JC Moon - Future Cardiology, 2011 - Taylor & Francis
Diffuse myocardial fibrosis (DMF) is an important marker in many cardiac diseases, but its
utility has been limited by the need for biopsy for its assessment. An accurate noninvasive …

Multimodality imaging assessment of myocardial fibrosis

S Gupta, Y Ge, A Singh, C Gräni, RY Kwong - Cardiovascular Imaging, 2021 - jacc.org
Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy

S Nakamori, K Dohi, M Ishida, Y Goto… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: The purpose of this study was to examine the histological correlation of native
myocardial T1 and extracellular volume fraction (ECV) measurement at 3-T for the …